Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

PDL BioPharma, Inc. (PDLI) 8.38 0.09
Price Open:8.20Day's Range:0.00000 - 8.90000
Price Close:8.2652wk Range:0.00000 - 8.90000
Price Day Change:0.09Volume:1,763,469
Price % Change:1.09Market Cap:1.169B
Bid:8.28000PE Ratio:5.46
Ask:8.38000EPS Diluted:1.514
Trade PDLI NOW!

The Latest On PDLI

UPDATE: Piper Jaffray Initiates PDL BioPharma at Neutral on Strong Royalties 5/15/13 6:32am
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer 4/30/13 4:03pm
PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger 4/22/13 12:52pm
Avinger, PDL BioPharma Close Mezzanine Financing 4/22/13 7:16am
Avinger, PDL Biopharma Close on $40M Structured Financing and Royalty Transaction 4/22/13 7:07am
PDL BioPharma Issues Q1 Royalty Outlook, Says Tysabri Sales Rose 16% in Q4 3/11/13 7:37am
UPDATE: J.P. Morgan Lowers PT on PDL BioPharma on Model Update 3/6/13 9:11am
Earnings Scheduled For March 1, 2013 3/1/13 5:55am
Mid-Afternoon Market Update: Markets Mixed, Given Drops After Company Abandons Sale 1/15/13 4:34pm
UPDATE: Credit Suisse Downgrades PDL Biopharma to Underperform on Valuation 1/15/13 1:32pm
Mid-Morning Market Update: Dell Continues to Rise While Lulu Lemon Takes a Hit 1/15/13 11:33am
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes 12/5/12 5:11pm
more
Press Releases
PDL BioPharma Announces First Quarter 2013 Financial Results 5/9/13 Newswire
PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013 5/2/13 Newswire
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer 4/30/13 Newswire
PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger 4/22/13 Newswire
Avinger Completes Mezzanine Financing with PDL Biopharma 4/22/13 Business Wire
PDL BioPharma Completes Regular Quarterly Dividend Payment 3/12/13 Newswire
PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million 3/11/13 Newswire
PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013 3/6/13 Newswire
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes 3/4/13 Newswire
PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results 3/1/13 Newswire
PDL BioPharma to Announce Fourth Quarter and Full Year 2012 Financial Results on March 1, 2013 2/25/13 Newswire
PDL BioPharma to Present at Two Upcoming Investor Conferences 2/20/13 Newswire

Get the latest PDLI stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for PDL BioPharma, Inc. stock price.

Partner Headlines
PDL BioPharma Misses Earnings Ests - Analyst Blog 5/13/13
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List 5/2/13
PDLI Guides Q1 Royalty Revenue - Analyst Blog 3/12/13
PDLI Beats on Higher Revenues - Analyst Blog 3/6/13
Company News for March 05, 2013 - Corporate Summary 3/5/13
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 2/27/13
20 Best Yielding Healthcare Growth Stocks and Which to Buy 2/2/13
PDLI Guides Q4 Royalty Rev to $86M - Analyst Blog 12/7/12
Bearish MACD for PDL BioPharma Inc. - Tale of the Tape 12/6/12
PDLI's EPS In Line, Revenue Misses - Analyst Blog 11/7/12
PDL BioPharma Inc. Reports Operating Results (10-Q) 11/5/12
AxoGen (AXGN) Continues to Grow in Regenerative Nerve Space 10/25/12